Alpha Tau Medical to Present at J.P. Morgan Healthcare Conference
Ticker: DRTSW · Form: 6-K · Filed: Dec 11, 2024 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | Dec 11, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: conference-presentation, healthcare
TL;DR
Alpha Tau Medical presenting at JPM Healthcare Conference on Dec 11.
AI Summary
Alpha Tau Medical Ltd. announced on December 11, 2024, that it will present at the 43rd Annual J.P. Morgan Healthcare Conference. The company, headquartered in Jerusalem, Israel, is a foreign private issuer filing a Form 6-K report.
Why It Matters
Participation in a major healthcare conference like J.P. Morgan's provides visibility and potential partnership opportunities for Alpha Tau Medical.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a conference presentation and does not contain significant financial or operational news.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- J.P. Morgan Healthcare Conference (company) — Event
- December 11, 2024 (date) — Announcement Date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report that Alpha Tau Medical Ltd. issued a press release on December 11, 2024, announcing its participation in the 43rd Annual J.P. Morgan Healthcare Conference.
When was the press release issued?
The press release was issued on December 11, 2024.
Which conference will Alpha Tau Medical Ltd. be presenting at?
Alpha Tau Medical Ltd. will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference.
Is Alpha Tau Medical Ltd. required to file Form 20-F or Form 40-F?
Alpha Tau Medical Ltd. indicates it files annual reports under cover of Form 20-F.
Where is Alpha Tau Medical Ltd. headquartered?
Alpha Tau Medical Ltd. is headquartered in Jerusalem, Israel.
Filing Stats: 302 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2024-12-11 08:32:27
Filing Documents
- ea0224322-6k_alpha.htm (6-K) — 11KB
- ea022432201ex99-1_alpha.htm (EX-99.1) — 7KB
- 0001213900-24-107659.txt ( ) — 19KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Alpha Tau Medical Ltd. Date: December 11, 2024 By: /s/ Uzi Sofer Uzi Sofer Chief Executive Officer 3